Product Program year 2025 Source: CMS Open Payments

Dermacell

Device Endoscopy

Open in the dashboard

General payments

$590,497

381 payments

Research payments

$0

0 payments

Through program year 2025, $590,497 in general payments and $0 in research payments were reported against Dermacell (Endoscopy).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

7 rows
Year Kind Amount Payments
2025 General $121,144 78
2024 General $5,217 84
2023 General $15 1
2022 General $764 16
2021 General $651 13
2020 General $24,611 12
2019 General $438,097 177

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $590,497 381 payments
Top recipients General payments · program year 2025
  1. David Weintritt Surgery · Alexandria, VA $23,000 19% · 2 payments
  2. Eleanor Bucholz Plastic and Reconstructive Surgery · Maywood, IL $15,575 13% · 2 payments
  3. Mark Venturi Plastic and Reconstructive Surgery · Mc Lean, VA $15,250 13% · 3 payments
  4. Jessica Maxwell Surgical Oncology · Omaha, NE $11,200 9% · 2 payments
  5. Anne Peled Plastic Surgery · San Francisco, CA $10,029 8% · 2 payments

The top 5 of 64 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Plastic and Reconstructive Surgery Surgery $41,852 35% · 18 practitioners
  2. Surgical Oncology Surgery $28,251 23% · 5 practitioners
  3. Plastic Surgery $26,441 22% · 17 practitioners
  4. Surgery $23,145 19% · 3 practitioners
  5. Physician Assistant $494 <1% · 6 practitioners

The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Virginia $38,250 32% · 2 recipients
  2. Illinois $15,657 13% · 2 recipients
  3. Nebraska $11,200 9% · 1 recipient
  4. Texas $11,104 9% · 18 recipients
  5. California $10,195 8% · 2 recipients

The top 5 of 20 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

381 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record